MedTrace Logo

Microbiome Test for the Detection of Colorectal Polyps and Cancer

NCT02141945 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 260

Last updated 2017-03-28

No results posted yet for this study

Summary

The purpose if this study is to measure the sensitivity, specificity and accuracy of the Metabiomics Colon Polyp and Colorectal Cancer Assay for the non-invasive detection of colon polyps or colorectal cancer.

Conditions

Sponsors & Collaborators

  • Metabiomics Corp

    lead INDUSTRY

Principal Investigators

  • Robert Hardi, M.D. · Metropolitan Gastroenterology Group

  • Louis Korman, M.D. · Metropolitan Gastroenterology Group

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2017-03-01
Completion
2017-03-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02141945 on ClinicalTrials.gov